Description

The American Thoracic Society (ATS), Centers for Disease Control and Prevention (CDC), and Infectious Diseases Society of America (IDSA) developed an algorithm for the treatment of a patient with possible tuberculosis and negative initial smears.


 

Patient selection:

(1) risk factors for tuberculosis

(2) positive tuberculin skin test

(3) abnormal chest X-ray and/or clinical symptoms

(4) negative sputum smears for acid fast bacilli (AFB)

(5) no other diagnosis

 

If the initial cultures are positive, then the person needs to be treated for active tuberculosis.

 

The differential diagnosis if the initial cultures are negative:

(1) active, culture-negative tuberculosis

(2) inactive tuberculosis

 

Parameters:

(1) suspicion for tuberculosis

(2) change in chest X-ray and clinical symptoms after initial 2 months

Level of Suspicion for Tuberculosis

Therapy During First 2 Months

Change After 2 Months

Subsequent Management

high

4 drug regimen (see below)

none

treatment complete (see note)

high

4 drug regimen (see below)

improvement

2 months INH and RIF

low

none

none

one of 3 regimens (below)

 

The 4 drug regimen includes:

(1) isoniazid (INH)

(2) rifampin (RIF)

(3) ethambutol (EMB)

(4) pyrazinamide (PZA)

 

NOTE: A multidrug-resistant strain of tuberculosis might not show improvement after 2 months of the 4 drug regimen.

 

Possible drug regimens for the patient with a low suspicion for active tuberculosis:

(1) rifampin plus pyrazinamide for 2 months

(2) rifampin with or without isoniazid for 4 months

(3) isoniazid for 9 months

 


To read more or access our algorithms and calculators, please log in or register.